期刊文献+

茎突后间隙侵犯与淋巴结N2期鼻咽癌预后的关系 被引量:2

Relationship of post-styloid space involvement with prognosis of patients with nasopharyngeal carcinoma in N2 stage
在线阅读 下载PDF
导出
摘要 目的探讨茎突后间隙侵犯对无远处转移且淋巴结分期为N2鼻咽癌患者预后的影响。方法收集149例淋巴结分期N2期初治鼻咽癌住院患者资料进行分析,均行CT扫描,采用单因素及多因素结合的方法分析茎突后间隙侵犯对其预后的影响。结果149例患者中,茎突后间隙无受侵的56例,茎突后间隙受侵的93例。单因素分析结果显示,茎突后间隙无侵犯、有侵犯的5年总生存率和5年无远处转移生存率分别为78.7%、49.7%(P=0.002)和86.4%、66.0%(P=0.014)。多因素分析结果显示,茎突后间隙侵犯为总生存率、无远处转移生存率的独立预后因素(P<0.05)。5年的总生存率为61.1%,5年局部区域无复发生存率为82.2%,5年无远处转移生存率为74.2%。结论茎突后间隙侵犯为淋巴结分期N2期鼻咽癌患者不利预后因素。 Objective To assess the prognosis influence of post-styloid space involvement of the patients with nasopharyngeal carcinoma (NPC) in the stage T1-4N2M0 (UICC2002 6th staging system). Methods 149 patients with NPC in N2 stage first treated in Sun Yat-sen university cancer center were analyzed. All the patients were examined by CT scan before treated. Potentially significant parameters were analyzed by both univariate analysis and multivariate analysis methods. Results There were 56 patients without post-styloid space involvement and 93 patients with post-styloid space involvement. In univariate analysis, the 5-year OS and DMF of patients with NPC in N2 stage without post-styloid space involvement and with it were 78.7% ,49.7%(P=0.002)and 86.4% ,66.0%(P=0.014). In multivariate analysis, post-styloid space involvement was an independent adverse prognosis factor of OS and DMF (P〈0.05). The 5-year overall survival rate (OS) was 61.1%. The 5-year local-regional free rate (LRF) was 82.2%. The 5-year distant metastasis free survival rate (DMF) was 74.2%. Conclusion In the N2 stage subgroup of NPC, the patients with post-styloid involvement have poorer prognosis.
出处 《解剖学研究》 CAS 2008年第2期136-140,共5页 Anatomy Research
基金 广东省科技计划项目(2006B36001009)
关键词 鼻咽癌/放射疗法 颈淋巴结 茎突后间隙 预后 Nasopharyngeal carcinoma/radiotherapy Neck lymph node Post-styloid space Prognosis
  • 相关文献

参考文献7

二级参考文献33

共引文献57

同被引文献32

  • 1刘亚群,邵振宇,李秀燕,王鲁仲.鼻咽癌的影像学诊断[J].中华肿瘤防治杂志,2006,13(13). 被引量:3
  • 2Lin JC,Liang WM,Jan JS,et al. Another way to estimate outcome of advanced nasopharyngeal carcinoma-is concurrent chemoradiotherapy adequate? [J]. Int J Rcdiat Oncol Biol Phys, 2004,60 ( 1 ) : 156-164.
  • 3Cheng SH, Yen KL, Jian JJ, et al. Examining prognostic factors and patterns of failure in nasopharyngeal carcinoma fol- lowing concomitant radiotherapy and chemotherapy: impact on future clinical trials[J]. Int J Radiat Oneol Biol Phys, 2001,50 (3) : 717-726.
  • 4Guigay J, Temam S, Bourhis J, et al. Nasopharyngeal carcinoma and therapeutic management., the place of chemotherapy[J]. Ann Oncol, 2006,17(Suppl 10) : x304-x307.
  • 5Lee AW, Sze WM, Au JS, et al. Treatment results for nasopha- ryngeal carcinoma in the modern era: the HongKong experi- ence[J].Int J Radiat Oncol Biol Phys, 2005,61 (4) :1107- 1116.
  • 6Leung TW, Tung SY, Sze WK, et al. Treatment results of 1070 patients with nasopharyngeal carcinoma., an analysis of survival and failure patterns [J]. Head Neek, 2005,27(7) : 555-565.
  • 7Ozyar E, Gurkaynak M, Yildiz F, et al. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival[J]. Radiother Oneol, 2004,72 ( 1 ) : 71-77.
  • 8Ozyar E,Selek U,Laskar S,et al. Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: A Rare Cancer Network study[J]. Radiother Oncol, 2006, 81 (1) :39-46.
  • 9Atasoy BM, Ozyar E, Akman F, et al. T4NOM0 nasopharyngeal carcinoma patients: do they have a distinct tumor biology? [J]. Kulak Burun Bogaz Ihtis Derg,2010,20(2) : 89-96.
  • 10Cheng SH, Tsai SP, Yen KL, et al. Prognostic significance of parapharyngeal space venous plexus and marrow involvement: potential landmarks of dissemination for stage I -III nasopharyngeal carcinoma [J]. Int J Radiat Oncol Biol Phys, 2005,61 (2) :456-465.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部